TP53 and in situ carcinoma: As miR-630 overexpression could partly diminish CIS-induced p53 (Figure 5i) due to targeting EP300 that acetylates p53,39,40 we suppose that the signal pathway in CIS-induced G1 arrest should differ from miR-630 transfection-resulted G1 arrest.